197 related articles for article (PubMed ID: 10868556)
1. Doses of olanzapine, risperidone, and haloperidol used in clinical practice: results of a prospective pharmacoepidemiologic study. EFESO Study Group. Estudio Farmacoepidemiologico en la Esquizofrenia con Olanzapina.
Sacristán JA; Gómez JC; Montejo AL; Vieta E; Gregor KJ
Clin Ther; 2000 May; 22(5):583-99. PubMed ID: 10868556
[TBL] [Abstract][Full Text] [Related]
2. [Incidence of extrapyramidal symptoms during treatment with olanzapine, haloperidol and risperidone: results of an observational study].
Sacristán JA; Gómez JC; Ferre F; Gascón J; Pérez Bravo A; Olivares JM
Actas Esp Psiquiatr; 2001; 29(1):25-32. PubMed ID: 11333516
[TBL] [Abstract][Full Text] [Related]
3. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
István S; Agoston T; Tamás T; Zoltán J
Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
[TBL] [Abstract][Full Text] [Related]
4. An integrated analysis of acute treatment-emergent extrapyramidal syndrome in patients with schizophrenia during olanzapine clinical trials: comparisons with placebo, haloperidol, risperidone, or clozapine.
Carlson CD; Cavazzoni PA; Berg PH; Wei H; Beasley CM; Kane JM
J Clin Psychiatry; 2003 Aug; 64(8):898-906. PubMed ID: 12927004
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine versus placebo and haloperidol: acute phase results of the North American double-blind olanzapine trial.
Beasley CM; Tollefson G; Tran P; Satterlee W; Sanger T; Hamilton S
Neuropsychopharmacology; 1996 Feb; 14(2):111-23. PubMed ID: 8822534
[TBL] [Abstract][Full Text] [Related]
6. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia.
Tran PV; Dellva MA; Tollefson GD; Beasley CM; Potvin JH; Kiesler GM
J Clin Psychiatry; 1997 May; 58(5):205-11. PubMed ID: 9184614
[TBL] [Abstract][Full Text] [Related]
7. Olanzapine vs haloperidol in geriatric schizophrenia: analysis of data from a double-blind controlled trial.
Kennedy JS; Jeste D; Kaiser CJ; Golshan S; Maguire GA; Tollefson G; Sanger T; Bymaster FP; Kinon BJ; Dossenbach M; Gilmore JA; Breier A
Int J Geriatr Psychiatry; 2003 Nov; 18(11):1013-20. PubMed ID: 14618553
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic switching versus augmentation among early non-responders to risperidone or olanzapine in acute-phase schizophrenia.
Hatta K; Otachi T; Fujita K; Morikawa F; Ito S; Tomiyama H; Abe T; Sudo Y; Takebayashi H; Yamashita T; Katayama S; Nakase R; Shirai Y; Usui C; Nakamura H; Ito H; Hirata T; Sawa Y;
Schizophr Res; 2014 Sep; 158(1-3):213-22. PubMed ID: 25086659
[TBL] [Abstract][Full Text] [Related]
9. The safety of olanzapine compared with other antipsychotic drugs: results of an observational prospective study in patients with schizophrenia (EFESO Study). Pharmacoepidemiologic Study of Olanzapine in Schizophrenia.
Gómez JC; Sacristán JA; Hernández J; Breier A; Ruiz Carrasco P; Antón Saiz C; Fontova Carbonell E
J Clin Psychiatry; 2000 May; 61(5):335-43. PubMed ID: 10847307
[TBL] [Abstract][Full Text] [Related]
10. Belgian Schizophrenia Outcome Survey - results of a 2-year naturalistic study in patients stabilised on monotherapy with olanzapine, risperidone or haloperidol.
Peuskens J; Gillain B; De Graeve D; Van Vleymen B; Albert A
Eur Psychiatry; 2009 Apr; 24(3):154-63. PubMed ID: 19118983
[TBL] [Abstract][Full Text] [Related]
11. The acute and long-term effect of olanzapine compared with placebo and haloperidol on serum prolactin concentrations.
Crawford AM; Beasley CM; Tollefson GD
Schizophr Res; 1997 Jul; 26(1):41-54. PubMed ID: 9376336
[TBL] [Abstract][Full Text] [Related]
12. Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients.
Bobes J; Gibert J; Ciudad A; Alvarez E; Cañas F; Carrasco JL; Gascón J; Gómez JC; Gutiérrez M
Prog Neuropsychopharmacol Biol Psychiatry; 2003 May; 27(3):473-81. PubMed ID: 12691783
[TBL] [Abstract][Full Text] [Related]
13. Optimal Dosing of Risperidone and Olanzapine in the Maintenance Treatment for Patients With Schizophrenia and Related Psychotic Disorders: A Retrospective Multicenter Study.
Yoshimura Y; Takeda T; Kishi Y; Harada T; Nomura A; Washida K; Yoshimura B; Sato K; Yada Y; Aoki S
J Clin Psychopharmacol; 2017 Jun; 37(3):296-301. PubMed ID: 28306616
[TBL] [Abstract][Full Text] [Related]
14. Risk of extrapyramidal syndromes with haloperidol, risperidone, or olanzapine.
Schillevoort I; de Boer A; Herings RM; Roos RA; Jansen PA; Leufkens HG
Ann Pharmacother; 2001 Dec; 35(12):1517-22. PubMed ID: 11793611
[TBL] [Abstract][Full Text] [Related]
15. Weight gain in patients with schizophrenia treated with risperidone, olanzapine, quetiapine or haloperidol: results of the EIRE study.
Bobes J; Rejas J; Garcia-Garcia M; Rico-Villademoros F; García-Portilla MP; Fernández I; Hernández G;
Schizophr Res; 2003 Jul; 62(1-2):77-88. PubMed ID: 12765747
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
[TBL] [Abstract][Full Text] [Related]
17. Extrapyramidal symptom profiles in Japanese patients with schizophrenia treated with olanzapine or haloperidol.
Inada T; Yagi G; Miura S
Schizophr Res; 2002 Oct; 57(2-3):227-38. PubMed ID: 12223254
[TBL] [Abstract][Full Text] [Related]
18. Risperidone versus haloperidol and amitriptyline in the treatment of patients with a combined psychotic and depressive syndrome.
Müller-Siecheneder F; Müller MJ; Hillert A; Szegedi A; Wetzel H; Benkert O
J Clin Psychopharmacol; 1998 Apr; 18(2):111-20. PubMed ID: 9555596
[TBL] [Abstract][Full Text] [Related]
19. Subjective response to antipsychotic treatment and compliance in schizophrenia. A naturalistic study comparing olanzapine, risperidone and haloperidol (EFESO Study).
García-Cabeza I; Gómez JC; Sacristán JA; Edgell E; González de Chavez M
BMC Psychiatry; 2001; 1():7. PubMed ID: 11835695
[TBL] [Abstract][Full Text] [Related]
20. Change in level of productivity in the treatment of schizophrenia with olanzapine or other antipsychotics.
Liu-Seifert H; Ascher-Svanum H; Osuntokun O; Jen KY; Gomez JC
BMC Psychiatry; 2011 May; 11():87. PubMed ID: 21586165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]